機会の不平等: ネパールを事例とした実証分析

早大学位記番号:新8376早稲田大

Realization of a density-dependent Peierls phase in a synthetic, spin-orbit coupled Rydberg system

We experimentally realize a Peierls phase in the hopping amplitude of excitations carried by Rydberg atoms, and observe the resulting characteristic chiral motion in a minimal setup of three sites. Our demonstration relies on the intrinsic spin-orbit coupling of the dipolar exchange interaction combined with time-reversal symmetry breaking by a homogeneous external magnetic field. Remarkably, the phase of the hopping amplitude between two sites strongly depends on the occupancy of the third site, thus leading to a correlated hopping associated to a density-dependent Peierls phase. We experimentally observe this density-dependent hopping and show that the excitations behave as anyonic particles with a non-trivial phase under exchange. Finally, we confirm the dependence of the Peierls phase on the geometrical arrangement of the Rydberg atoms.Comment: 10 pages, 7 figure

One Tree to Rule Them All: Optimizing GGM Trees and OWFs for Post-Quantum Signatures

The use of MPC-in-the-Head (MPCitH)-based zero-knowledge proofs of knowledge (ZKPoK) to prove knowledge of a preimage of a one-way function (OWF) is a popular approach towards constructing efficient post-quantum digital signatures. Starting with the Picnic signature scheme, many optimized MPCitH signatures using a variety of (candidate) OWFs have been proposed. Recently, Baum et al. (CRYPTO 2023) showed a fundamental improvement to MPCitH, called VOLE-in-the-Head (VOLEitH), which can generically reduce the signature size by at least a factor of two without decreasing computational performance or introducing new assumptions. Based on this, they designed the FAEST signature which uses AES as the underlying OWF. However, in comparison to MPCitH, the behavior of VOLEitH when using other OWFs is still unexplored. In this work, we improve a crucial building block of the VOLEitH and MPCitH approaches, the so-called all-but-one vector commitment, thus decreasing the signature size of VOLEitH and MPCitH signature schemes. Moreover, by introducing a small Proof of Work into the signing procedure, we can improve the parameters of VOLEitH (further decreasing signature size) without compromising the computational performance of the scheme. Based on these optimizations, we propose three VOLEitH signature schemes FAESTER, KuMQuat, and MandaRain based on AES, MQ, and Rain, respectively. We carefully explore the parameter space for these schemes and implement each, showcasing their performance with benchmarks. Our experiments show that these three signature schemes outperform MPCitH-based competitors that use comparable OWFs, in terms of both signature size and signing/verification time

High Performance Multi-Party Computation for Binary Circuits Based on Oblivious Transfer

We present a unified view of the two-party and multi-party computation protocols based on oblivious transfer first outlined in Nielsen \emph{et al.} (CRYPTO 2012) and Larraia et al. (CRYPTO 2014). We present a number of modifications and improvements to these earlier presentations, as well as full proofs of the entire protocol. Improvements include a unified pre-processing and online MAC methodology, mechanisms to pass between different MAC variants, and fixing a minor bug in the protocol of Larraia \emph{et al.}~in relation to a selective failure attack. It also fixes a minor bug in Nielsen \emph{et al.} resulting from using Jensen\u27s inequality in the wrong direction in an analysis

Realization of a density-dependent Peierls phase in a synthetic, spin-orbit coupled Rydberg system

We experimentally realize a Peierls phase in the hopping amplitude of excitations carried by Rydberg atoms, and observe the resulting characteristic chiral motion in a minimal setup of three sites. Our demonstration relies on the intrinsic spin-orbit coupling of the dipolar exchange interaction combined with time-reversal symmetry breaking by a homogeneous external magnetic field. Remarkably, the phase of the hopping amplitude between two sites strongly depends on the occupancy of the third site, thus leading to a correlated hopping associated with a density-dependent Peierls phase. We experimentally observe this density-dependent hopping and show that the excitations behave as anyonic particles with a nontrivial phase under exchange. Finally, we confirm the dependence of the Peierls phase on the geometrical arrangement of the Rydberg atoms.This project has receveid funding from the European Union’s Horizon 2020 research and innovation program under Grant Agreement No. 817482 (PASQuanS), by the Region Île-de-France in the framework of DIM SIRTEQ (project CARAQUES), by the IXCORE-Fondation pour la Recherche as well as the French-German collaboration for joint projects in NLE Sciences funded by the Deutsche Forschungsgemeinschaft (DFG) and the Agence National de la Recherche (ANR, project RYBOTIN). M. F. is supported by the Deutsche Forschungsgemeinschaft (DFG) through SFB TR185, Project No. 277625399. H. P. B. is supported by the European Union under the ERC consolidator grant SIRPOL (Grant No. 681208). H. P. B., A. B., and M. F. thank the KITP for hospitality. This research was also supported in part by the National Science Foundation under Grant No. NSF PHY-1748958.Peer reviewe

Cabbage and fermented vegetables : From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Large differences in COVID-19 death rates exist between countries and between regions of the same country. Some very low death rate countries such as Eastern Asia, Central Europe, or the Balkans have a common feature of eating large quantities of fermented foods. Although biases exist when examining ecological studies, fermented vegetables or cabbage have been associated with low death rates in European countries. SARS-CoV-2 binds to its receptor, the angiotensin-converting enzyme 2 (ACE2). As a result of SARS-CoV-2 binding, ACE2 downregulation enhances the angiotensin II receptor type 1 (AT(1)R) axis associated with oxidative stress. This leads to insulin resistance as well as lung and endothelial damage, two severe outcomes of COVID-19. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is the most potent antioxidant in humans and can block in particular the AT(1)R axis. Cabbage contains precursors of sulforaphane, the most active natural activator of Nrf2. Fermented vegetables contain many lactobacilli, which are also potent Nrf2 activators. Three examples are: kimchi in Korea, westernized foods, and the slum paradox. It is proposed that fermented cabbage is a proof-of-concept of dietary manipulations that may enhance Nrf2-associated antioxidant effects, helpful in mitigating COVID-19 severity.Peer reviewe

Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies

There are large between- and within-country variations in COVID-19 death rates. Some very low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have a common feature of eating large quantities of fermented foods whose intake is associated with the activation of the Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) anti-oxidant transcription factor. There are many Nrf2-interacting nutrients (berberine, curcumin, epigallocatechin gallate, genistein, quercetin, resveratrol, sulforaphane) that all act similarly to reduce insulin resistance, endothelial damage, lung injury and cytokine storm. They also act on the same mechanisms (mTOR: Mammalian target of rapamycin, PPAR gamma:Peroxisome proliferator-activated receptor, NF kappa B: Nuclear factor kappa B, ERK: Extracellular signal-regulated kinases and eIF2 alpha:Elongation initiation factor 2 alpha). They may as a result be important in mitigating the severity of COVID-19, acting through the endoplasmic reticulum stress or ACE-Angiotensin-II-AT(1)R axis (AT(1)R) pathway. Many Nrf2-interacting nutrients are also interacting with TRPA1 and/or TRPV1. Interestingly, geographical areas with very low COVID-19 mortality are those with the lowest prevalence of obesity (Sub-Saharan Africa and Asia). It is tempting to propose that Nrf2-interacting foods and nutrients can re-balance insulin resistance and have a significant effect on COVID-19 severity. It is therefore possible that the intake of these foods may restore an optimal natural balance for the Nrf2 pathway and may be of interest in the mitigation of COVID-19 severity

Variation in general supportive and preventive intensive care management of traumatic brain injury: a survey in 66 neurotrauma centers participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study

Abstract Background General supportive and preventive measures in the intensive care management of traumatic brain injury (TBI) aim to prevent or limit secondary brain injury and optimize recovery. The aim of this survey was to assess and quantify variation in perceptions on intensive care unit (ICU) management of patients with TBI in European neurotrauma centers. Methods We performed a survey as part of the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. We analyzed 23 questions focused on: 1) circulatory and respiratory management; 2) fever control; 3) use of corticosteroids; 4) nutrition and glucose management; and 5) seizure prophylaxis and treatment. Results The survey was completed predominantly by intensivists (n = 33, 50%) and neurosurgeons (n = 23, 35%) from 66 centers (97% response rate). The most common cerebral perfusion pressure (CPP) target was > 60 mmHg (n = 39, 60%) and/or an individualized target (n = 25, 38%). To support CPP, crystalloid fluid loading (n = 60, 91%) was generally preferred over albumin (n = 15, 23%), and vasopressors (n = 63, 96%) over inotropes (n = 29, 44%). The most commonly reported target of partial pressure of carbon dioxide in arterial blood (PaCO2) was 36–40 mmHg (4.8–5.3 kPa) in case of controlled intracranial pressure (ICP) < 20 mmHg (n = 45, 69%) and PaCO2 target of 30–35 mmHg (4–4.7 kPa) in case of raised ICP (n = 40, 62%). Almost all respondents indicated to generally treat fever (n = 65, 98%) with paracetamol (n = 61, 92%) and/or external cooling (n = 49, 74%). Conventional glucose management (n = 43, 66%) was preferred over tight glycemic control (n = 18, 28%). More than half of the respondents indicated to aim for full caloric replacement within 7 days (n = 43, 66%) using enteral nutrition (n = 60, 92%). Indications for and duration of seizure prophylaxis varied, and levetiracetam was mostly reported as the agent of choice for both seizure prophylaxis (n = 32, 49%) and treatment (n = 40, 61%). Conclusions Practice preferences vary substantially regarding general supportive and preventive measures in TBI patients at ICUs of European neurotrauma centers. These results provide an opportunity for future comparative effectiveness research, since a more evidence-based uniformity in good practices in general ICU management could have a major impact on TBI outcome

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570